Atossa Therapeutics Gross Margin Growth & History (ATOS)

Atossa Therapeutics's gross margin was −7,431.91% for fiscal 2015.

View full Atossa Therapeutics company overview

Atossa Therapeutics annual gross margin history

Atossa Therapeutics annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20152015-12-31−7,431.91%−7531.91 pp
20142014-12-31100.00%+78.33 pp
20132013-12-3121.67%−64.71 pp
20122012-12-3186.38%+6465.71 pp
20112011-12-31−6,379.33%

Atossa Therapeutics gross margin trends

Across the available reported history, Atossa Therapeutics's gross margin decreased from 100.00% to −7,431.91%, a change of −7531.91 percentage points. The latest reported quarter, Q4 2015, shows −33,531.91%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Atossa Therapeutics filings at SEC.gov ↗